Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi

INTRODUCTION: Few patients with type 2 diabetes mellitus (T2DM) achieve recommended glycemic control targets in the Czech Republic. Novel therapies, such as fixed-ratio combinations of basal insulin plus glucagon-like peptide-1 receptor agonists, may contribute to better glycemic control. In the ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Pöhlmann, Johannes, Russel-Szymczyk, Monika, Holík, Pavel, Rychna, Karel, Hunt, Barnaby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437226/
https://www.ncbi.nlm.nih.gov/pubmed/30706364
http://dx.doi.org/10.1007/s13300-019-0569-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437226/
https://www.ncbi.nlm.nih.gov/pubmed/30706364
http://dx.doi.org/10.1007/s13300-019-0569-7

Ejemplares similares